EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Combination therapy of glutathione and resveratrol: a promising approach in the management of melasma

Abdullah Demirbaş iD, Gözde Ulutaş

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17191 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Abdullah Demirbaş und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey. Hauptthemen laut MEDLINE: Resveratrol, Melanosis, Glutathione, Drug Therapy, Combination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolMelanosisGlutathioneDrug Therapy, CombinationHumansFemaleAntioxidantsAdultStilbenesTreatment Outcome

Stichwörter der Autor:innen

combination therapy and antioxidant therapyglutathionemelasmaoral treatmentresveratrol

Substanzen

ResveratrolGlutathioneAntioxidantsStilbenes

Autor:innen und Institutionen

  • Department of Dermatology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.
  • Department of Dermatology, Kocaeli City Hospital, Kocaeli, Turkey.

ORCID-Profile: Abdullah Demirbaş

Zitieren

APA

Demirbaş, A., & Ulutaş, G. (2024). Combination therapy of glutathione and resveratrol: a promising approach in the management of melasma. International Journal of Dermatology. https://doi.org/10.1111/ijd.17191

Vancouver

Demirbaş A, Ulutaş G. Combination therapy of glutathione and resveratrol: a promising approach in the management of melasma. International Journal of Dermatology. 2024. doi:10.1111/ijd.17191

BibTeX
@article{Demirba2024,
  author = {Demirbaş, Abdullah and Ulutaş, Gözde},
  title = {Combination therapy of glutathione and resveratrol: a promising approach in the management of melasma},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17191}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche